Giles Turner, from Brighton, is one of the men who could benefit from the drug Men with aggressive prostate cancer should be given a drug that halves their risk of death, experts have urged the NHS.

A new artificial intelligence (AI) test can identify which men with prostate cancer will benefit most from the life-extending drug abiraterone, in clinical trial results presented by scientists from ...

Prostate cancer remains a global health challenge, ranking as the second most common malignancy among men. While early-stage disease can be effectively managed, advanced forms-particularly metastatic ...

The UK’s approach to prostate cancer is failing men from pre-diagnosis through to advanced disease management, according to new reports. Experts cite three critical failings: the lack of a screening ...

When travel writer Rick Steves, 70, switched insurance providers, he visited a new doctor, who suggested Steves undergo a prostate-specific antigen (PSA) test. Steves agreed. “He called me two days ...